Gene expression profile association with poor prognosis in epithelial ovarian cancer patients

Abstract Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management either lack specificity or are very costly. Gene expression profiling has shown to be a very effective tool in exploring new molecular...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Douglas V. N. P. Oliveira, Kira P. Prahm, Ib J. Christensen, Anker Hansen, Claus K. Høgdall, Estrid V. Høgdall
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ad7576e2e7204848a35416de869b709c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad7576e2e7204848a35416de869b709c
record_format dspace
spelling oai:doaj.org-article:ad7576e2e7204848a35416de869b709c2021-12-02T13:34:46ZGene expression profile association with poor prognosis in epithelial ovarian cancer patients10.1038/s41598-021-84953-92045-2322https://doaj.org/article/ad7576e2e7204848a35416de869b709c2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84953-9https://doaj.org/toc/2045-2322Abstract Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management either lack specificity or are very costly. Gene expression profiling has shown to be a very effective tool in exploring new molecular markers for patients with OC, although association of such markers with patient survival and clinical outcome is still elusive. Here, we performed gene expression profiling of different subtypes of OC to evaluate its association with patient overall survival (OS) and aggressive forms of the disease. By global mRNA microarray profiling in a total of 196 epithelial OC patients (161 serous, 15 endometrioid, 11 mucinous, and 9 clear cell carcinomas), we found four candidates—HSPA1A, CD99, RAB3A and POM121L9P, which associated with OS and poor clinicopathological features. The overexpression of all combined was correlated with shorter OS and progression-free survival (PFS). Furthermore, the combination of at least two markers were further associated with advanced grade, chemotherapy resistance, and progressive disease. These results indicate that a panel comprised of a few predictors that associates with a more aggressive form of OC may be clinically relevant, presenting a better performance than one marker alone.Douglas V. N. P. OliveiraKira P. PrahmIb J. ChristensenAnker HansenClaus K. HøgdallEstrid V. HøgdallNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Douglas V. N. P. Oliveira
Kira P. Prahm
Ib J. Christensen
Anker Hansen
Claus K. Høgdall
Estrid V. Høgdall
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
description Abstract Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management either lack specificity or are very costly. Gene expression profiling has shown to be a very effective tool in exploring new molecular markers for patients with OC, although association of such markers with patient survival and clinical outcome is still elusive. Here, we performed gene expression profiling of different subtypes of OC to evaluate its association with patient overall survival (OS) and aggressive forms of the disease. By global mRNA microarray profiling in a total of 196 epithelial OC patients (161 serous, 15 endometrioid, 11 mucinous, and 9 clear cell carcinomas), we found four candidates—HSPA1A, CD99, RAB3A and POM121L9P, which associated with OS and poor clinicopathological features. The overexpression of all combined was correlated with shorter OS and progression-free survival (PFS). Furthermore, the combination of at least two markers were further associated with advanced grade, chemotherapy resistance, and progressive disease. These results indicate that a panel comprised of a few predictors that associates with a more aggressive form of OC may be clinically relevant, presenting a better performance than one marker alone.
format article
author Douglas V. N. P. Oliveira
Kira P. Prahm
Ib J. Christensen
Anker Hansen
Claus K. Høgdall
Estrid V. Høgdall
author_facet Douglas V. N. P. Oliveira
Kira P. Prahm
Ib J. Christensen
Anker Hansen
Claus K. Høgdall
Estrid V. Høgdall
author_sort Douglas V. N. P. Oliveira
title Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
title_short Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
title_full Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
title_fullStr Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
title_full_unstemmed Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
title_sort gene expression profile association with poor prognosis in epithelial ovarian cancer patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ad7576e2e7204848a35416de869b709c
work_keys_str_mv AT douglasvnpoliveira geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients
AT kirapprahm geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients
AT ibjchristensen geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients
AT ankerhansen geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients
AT clauskhøgdall geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients
AT estridvhøgdall geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients
_version_ 1718392756780400640